CEO of Cell Therapeutics Inc. (CTIC, Financial) James A Bianco sells 150,000 shares of CTIC on 12/10/2010 at an average price of $0.37 a share.
Cell Therapeutics Inc. has a market cap of $304.3 million; its shares were traded at around $0.3735 with and P/S ratio of 3804.
CTIC is in the portfolios of Steven Cohen of SAC Capital Advisors.
Cell Therapeutics Inc. has a market cap of $304.3 million; its shares were traded at around $0.3735 with and P/S ratio of 3804.
CTIC is in the portfolios of Steven Cohen of SAC Capital Advisors.
CEO Recent Trades:
- Sell: CEO James A Bianco sold 100,000 shares of CTIC stock on 11/05/2010 at the average price of 0.39. James A Bianco owns at least 12,922,660 shares after this. The price of the stock has decreased by 4.23% since.
- Sell: CEO James A Bianco sold 400,000 shares of CTIC stock on 09/30/2010 at the average price of 0.38. James A Bianco owns at least 13,022,660 shares after this. The price of the stock has decreased by 1.71% since.
- Sell: CEO James A Bianco sold 250,000 shares of CTIC stock on 08/10/2010 at the average price of 0.4. James A Bianco owns at least 13,422,660 shares after this. The price of the stock has decreased by 6.63% since.
- Sell: CEO James A Bianco sold 500,000 shares of CTIC stock on 06/30/2010 at the average price of 0.37. James A Bianco owns at least 3,706,050 shares after this. The price of the stock has increased by 0.95% since.
Directors and Officers Recent Trades:
- Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 11/30/2010 at the average price of 0.35. Phillip M Phd Nudelman owns at least 2,354,865 shares after this. The price of the stock has increased by 6.71% since.
- Sell: Director Richard L Love sold 75,000 shares of CTIC stock on 11/22/2010 at the average price of 0.39. Richard L Love owns at least 2,302,773 shares after this. The price of the stock has decreased by 4.23% since.
- Sell: Director Fred Telling sold 216,016 shares of CTIC stock on 11/05/2010 at the average price of 0.39. Fred Telling owns at least 1,587,907 shares after this. The price of the stock has decreased by 4.23% since.
- Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 10/29/2010 at the average price of 0.38. Phillip M Phd Nudelman owns at least 2,394,865 shares after this. The price of the stock has decreased by 1.71% since.
- Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 09/30/2010 at the average price of 0.38. Phillip M Phd Nudelman owns at least 2,434,865 shares after this. The price of the stock has decreased by 1.71% since.
